S2355

1) What happened and its current status: S2355 was introduced July 17, 2025 by Sen. Marshall (R-KS) with 20 cosponsors including bipartisan support. It was referred to the HELP Committee and hearings were held March 19, 2026. The bill remains in committee markup stage. A companion bill HR5582 exists in the House. The bill has not passed either chamber. 2) The money trail: This bill authorizes ZERO dollars. It is a regulatory mandate, not a spending bill. It requires hospitals and insurers to publish pricing data at their own expense. There is no federal funding for implementation. The Congressional Budget Office would likely score this as reducing federal spending slightly (through lower Medicare/Medicaid payments if transparency reduces prices), but no appropriation is needed. 3) Structural winners and losers: Winners are patients and self-insured employers who gain price comparison tools. Losers are hospitals and insurers that must invest in compliance infrastructure. HCA ($HCA) and UnitedHealth face compliance costs but these are immaterial relative to their revenues ($65B and $371.6B respectively). Smaller hospitals and regional insurers face proportionally higher compliance burdens. No tickers show clear bullish or bearish signals above the confidence threshold. 4) Competitive landscape: Hospital price transparency has been a regulatory goal since 2019 CMS rules. Many hospitals already comply partially. This bill would standardize and expand requirements. The impact on stock prices is minimal because the market has already priced in ongoing transparency trends. 5) Timeline: The bill must pass the HELP Committee, then the full Senate, then the House (where HR5582 is pending in three committees), then be signed by the President. With hearings held but no markup scheduled, passage in the 119th Congress is uncertain. Midterm elections in November 2026 add time pressure.